Beneficial effects of ACTH on the serum lipoprotein profile and glomerular function in patients with membranous nephropathy
- 1 October 1999
- journal article
- clinical trial
- Published by Elsevier in Kidney International
- Vol. 56 (4) , 1534-1543
- https://doi.org/10.1046/j.1523-1755.1999.00675.x
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Adrenocorticotrophic hormone lowers serum Lp(a) and LDL cholesterol concentrations in hemodialysis patientsKidney International, 1997
- ACTH lowers serum lipids in steroid-treated hyperlipemic patients with kidney diseaseKidney International, 1996
- Lipid-lowering therapy in patients with renal diseaseKidney International, 1995
- Lipids and the kidneyKidney International, 1994
- Lipid Abnormalities in the Nephrotic Syndrome: Causes, Consequences, and TreatmentAmerican Journal of Kidney Diseases, 1994
- Direct effects of corticotropin on plasma lipoprotein metabolism in man—Studies in vivo and in vitroMetabolism, 1994
- The increased risk of coronary heart disease associated with nephrotic syndromeKidney International, 1993
- ACTH 1-24 decreases hepatic lipase activities and low density lipoprotein concentrations in healthy menJournal of Internal Medicine, 1991
- Controlled Trial of Methylprednisolone and Chlorambucil in Idiopathic Membranous NephropathyNew England Journal of Medicine, 1984
- Treatment of Idiopathic Membranous NephropathyNew England Journal of Medicine, 1976